Leerink Partners, Truist Financial, HSBC, and Cantor Fitzgerald raised target prices on various stocks on October 9, 2026.

The entities involved

• Leerink partners →

  U.S. investment bank

  • Leerink Partners upgraded Gossamer Bio stock rating on September 26, 2026.15:13
  • Leerink Partners assumed coverage on Nektar Therapeutics shares on October 13, 2026.07:48
• Truist Financial →

  American bank holding company, formerly known as BB&T Corporation

  • Truist Financial and Citigroup issued new ratings and target prices for Accel Entertainment.06:42
  • Analyst target price raises outlook for Owens Corning, involving reports from Truist Financial and Royal Bank of Canada.Mon 19:46
• Cantor Fitzgerald →

  American financial services company

  • Analyst firms issued price targets and ratings involving Benchmark, Booking Holdings, and Cantor Fitzgerald.07:52
  • Cantor Fitzgerald increased its price target and rating for Hyperliquid Strategies, while MarketBeat provided consensus rating data.07:07

Related events

• Cantor Fitzgerald and Wells Fargo raised price targets for Regeneron Pharmaceuticals stock.Sep 10
• Multiple financial institutions, including Goldman Sachs, JPMorgan Chase, and UBS, issued various target price changes on shares.Mon 10:48
• Cantor Fitzgerald raised its price target and rating for Supernus Pharmaceuticals, Inc. on September 2, 2026, and the company filed a disclosure with the SEC.Sep 2
• Leerink raised its price target for UnitedHealth Group stock.Jun 19
• Truist Financial and Leerink Partners raised price objectives for Eli Lilly and Company stock.Sep 2